首页> 外国专利> STRATEGIES FOR DESIGNING DRUGS THAT TARGET THE SIR2 FAMILY OF ENZYMES

STRATEGIES FOR DESIGNING DRUGS THAT TARGET THE SIR2 FAMILY OF ENZYMES

机译:靶向SIR2酶家族的药物设计策略

摘要

The instant invention describes methods of identifying compounds that modulate the activity of Sir2 enzymes. Sir2 enzymes form a unique class Of NAD+ dependent deacetylases required for diverse biological processes including transcriptional silencing, regulation of apoptosis, fat mobilization, and lifespan regulation. Sir2 activity is regulated by nicotinamide, a non-competitive inhibitor that promotes a base exchange reaction at the expense of deacetylation.
机译:本发明描述了鉴定调节Sir2酶活性的化合物的方法。 Sir2酶形成一类独特的NAD +依赖性脱乙酰基酶,是多种生物过程所必需的,这些过程包括转录沉默,凋亡调控,脂肪动员和寿命调控。 Sir2的活性受到烟酰胺的调节,烟酰胺是一种非竞争性的抑制剂,它以脱乙酰基为代价促进碱基交换反应。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号